GB553190A - Process for the manufacture of therapeutically valuable derivatives of abietic acid - Google Patents
Process for the manufacture of therapeutically valuable derivatives of abietic acidInfo
- Publication number
- GB553190A GB553190A GB926/42A GB92642A GB553190A GB 553190 A GB553190 A GB 553190A GB 926/42 A GB926/42 A GB 926/42A GB 92642 A GB92642 A GB 92642A GB 553190 A GB553190 A GB 553190A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- abietic acid
- alkali
- derivatives
- abietic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
553,190. Abietic acid derivatives. HOFFMANN-LA-ROCHE & CO. AKT.-GES., F. Jan. 22, 1942, Nos. 926 and 927. Convention dates, March 26, 1941, and April 3, 1941. [Class 2 (iii)] Derivatives of abietic acid having therapeutic properties are made by treating one molecule of halogen-trihydroxy - abietic acid with 1¢ molecules of alkali, or tetrahydroxy-abietic acid with half the quantity of alkali required for neutralisation, or 2 molecules of tetrahydroxyabietic acid alkali salt with one molecule of acid. A complex compound is obtained containing one free carboxylic acid group and one alkali carboxylate group. Bromo-trihydroxyabietic acid, which is prepared in the same way as chloro-trihydroxy abietic acid but using HBe instead of HCl, may be used as starting material. Both the sodium and potassium compounds are prepared using the corresponding alcoholic alkali hydroxide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH553190X | 1941-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB553190A true GB553190A (en) | 1943-05-11 |
Family
ID=4519794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB926/42A Expired GB553190A (en) | 1941-03-26 | 1942-01-22 | Process for the manufacture of therapeutically valuable derivatives of abietic acid |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB553190A (en) |
-
1942
- 1942-01-22 GB GB926/42A patent/GB553190A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR790000113B1 (en) | Method for preparation of dopamine derivatives | |
GB553190A (en) | Process for the manufacture of therapeutically valuable derivatives of abietic acid | |
ES454084A1 (en) | Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding) | |
ES388880A1 (en) | 1-(2'-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof | |
GB555346A (en) | Process for the manufacture of aqueous lactoflavin solutions | |
ES417396A1 (en) | A procedure for the production of a pharmaceutical composition. (Machine-translation by Google Translate, not legally binding) | |
ES257899A1 (en) | Improvements in or relating to process for the manufacture of therapeutic useful preparations of iron | |
GB191221616A (en) | Improvements in the Manufacture and Production of Methylbutenol Esters. | |
ES451091A1 (en) | Improvement concerning about organic compound | |
GB916097A (en) | New penicillin | |
GB509804A (en) | Process for the manufacture of sulphinic acid derivatives | |
GB662830A (en) | A process for the manufacture of 3-hydroxy-n-methyl morphinane | |
ES365157A1 (en) | A procedure for preparing new derivatives of alpha-6-desoxy-5-oxytetraciclines (Machine-translation by Google Translate, not legally binding) | |
GB502786A (en) | A process for the preparation of aqueous solutions of p-aminobenzenesulphonamide particularly for injection purposes | |
NL39301C (en) | ||
ES433553A1 (en) | Disbustistuted xanthone carboxylic acid compounds | |
GB1321276A (en) | Dibenzocycloheptene derivatives | |
GB703961A (en) | Improvements in derivatives of stilbazoline | |
GB418404A (en) | A process for the production of a compound of theophylline and ethanolamine | |
GB569683A (en) | Improvements in or relating to glycerol fermentation process | |
GB807849A (en) | Improvements in or relating to the production of cystine | |
ES379618A1 (en) | Amino acids and derivatives thereof and a process for the manufacture of same | |
GB506431A (en) | Benzenesulfonhydroxamide derivatives and process of producing them | |
ES382622A1 (en) | Procedure for the preparation of a new derivative of tiepine. (Machine-translation by Google Translate, not legally binding) | |
GB673101A (en) | Improvements in or relating to insoluble salt of penicillin and process of preparing the same |